AMDR Statement: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™
23 September 2024 Statement from AMDR: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™ In September 2020, a Medtronic-funded study purporting to show soiled reprocessed LigaSure devices was published in the Journal
AMDR Action Alert: Your Voice Matters – Hospital Purchasing Representatives Encouraged to Report Anticompetitive SUD Purchasing Contracts and Related Behavior
Last December, the Biden Administration declared war on corporate greed in healthcare. The announcement included a range of fronts in the war, from fighting bloated drug costs to attacking anticompetitive contracts that cause unnecessary waste
AMDR Statement: FDA’s Recently Published Guidance Document, “Remanufacturing of Medical Devices,” Addresses Reusable Devices, not Reprocessed Single-Use Devices
On May 10th, 2024, the U.S. Food and Drug Administration issued final guidance titled, “Remanufacturing of Medical Devices: Guidance for Industry, Entities That Perform Servicing or Remanufacturing, and Food and Drug Administration Staff.” AMDR wishes